标题
Myeloma bone disease: pathogenesis, current treatments and future targets
作者
关键词
-
出版物
BRITISH MEDICAL BULLETIN
Volume 111, Issue 1, Pages 117-138
出版商
Oxford University Press (OUP)
发表日期
2014-09-05
DOI
10.1093/bmb/ldu016
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sotatercept in patients with osteolytic lesions of multiple myeloma
- (2014) Kudrat M. Abdulkadyrov et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immunomodulatory drugs thalidomide and lenalidomide affect osteoblast differentiation of human bone marrow stromal cells in vitro
- (2014) Arnold Bolomsky et al. EXPERIMENTAL HEMATOLOGY
- Strahlentherapie bei solitärem Plasmozytom und multiplem Myelom
- (2014) M.C. Schmaus et al. RADIOLOGE
- Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma
- (2013) Kate Vandyke et al. BRITISH JOURNAL OF HAEMATOLOGY
- Repetitively dosed docetaxel and153samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer
- (2013) Karen A. Autio et al. CANCER
- Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis
- (2013) Lydia Gedmintas et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Living With Advanced But Stable Multiple Myeloma: A Study of the Symptom Burden and Cumulative Effects of Disease and Intensive (Hematopoietic Stem Cell Transplant-Based) Treatment on Health-Related Quality of Life
- (2013) Elaine Boland et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma
- (2013) R Silbermann et al. LEUKEMIA
- Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)
- (2013) Jan A. Burger et al. LEUKEMIA & LYMPHOMA
- Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma
- (2013) Bo Hu et al. PLoS One
- Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy
- (2012) E. Terpos et al. ANNALS OF ONCOLOGY
- BTK inhibition in myeloma: targeting the seed and the soil
- (2012) C. M. Edwards BLOOD
- CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease
- (2012) D. J. Dairaghi et al. BLOOD
- Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
- (2012) Y.-T. Tai et al. BLOOD
- Atypical metatarsal fracture in a patient on long term bisphosphonate therapy
- (2012) Vikas Saxena et al. Indian Journal of Orthopaedics
- Strontium ranelate – a promising therapeutic principle in osteoporosis
- (2012) Georges Boivin et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects
- (2012) M A Hurchla et al. LEUKEMIA
- Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?
- (2012) J E Noll et al. Blood Cancer Journal
- Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease
- (2011) S. D'Souza et al. BLOOD
- Guidelines for supportive care in multiple myeloma 2011
- (2011) John A. Snowden et al. BRITISH JOURNAL OF HAEMATOLOGY
- Update on Wnt signaling in bone cell biology and bone disease
- (2011) David G. Monroe et al. GENE
- N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation
- (2011) R. W. J. Groen et al. HAEMATOLOGICA
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Osteoporosis: now and the future
- (2011) Tilman D Rachner et al. LANCET
- Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
- (2011) M A Dimopoulos et al. LEUKEMIA
- Giant Nonmonotonic Stretching Response of a Self-Associating Polymer in Shear Flow
- (2011) Charles E. Sing et al. PHYSICAL REVIEW LETTERS
- Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone
- (2010) J.-L. Harousseau et al. BLOOD
- TGF-β-related mechanisms of bone destruction in multiple myeloma
- (2010) Toshio Matsumoto et al. BONE
- Osteoblast function in myeloma
- (2010) G. David Roodman BONE
- Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance
- (2010) Anita Škrtić et al. HUMAN PATHOLOGY
- Interleukin-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone
- (2010) Sakamuri V. Reddy et al. JOURNAL OF BONE AND MINERAL RESEARCH
- TNF-α's effects on proliferation and apoptosis in human mesenchymal stem cells depend on RUNX2 expression
- (2010) Olfa Ghali et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Zoledronic acid in myeloma: MRC Myeloma IX
- (2010) S Vincent Rajkumar LANCET
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
- (2010) Gareth J Morgan et al. LANCET
- Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone
- (2010) Angela Pennisi et al. PLoS One
- Adhesion molecules—The lifelines of multiple myeloma cells
- (2010) Ben-Zion Katz SEMINARS IN CANCER BIOLOGY
- Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides: Part II
- (2009) William J. Moore et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Bortezomib induces osteoblast differentiation via Wnt-independent activation of -catenin/TCF signaling
- (2009) Y.-W. Qiang et al. BLOOD
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
- (2009) M. Fulciniti et al. BLOOD
- VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Multiple Myeloma With Moderately Impaired Renal Function, and Results in Reversal of Renal Impairment: Cohort Analysis of the Phase III VISTA Study
- (2009) Meletios A. Dimopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone
- (2009) P. D. Ottewell et al. MOLECULAR CANCER THERAPEUTICS
- Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone
- (2009) Khalid S. Mohammad et al. PLoS One
- Functions of RANKL/RANK/OPG in bone modeling and remodeling
- (2008) Brendan F. Boyce et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Geranylgeranyl transferase type II inhibition prevents myeloma bone disease
- (2008) Michelle A. Lawson et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma
- (2008) Pellegrino Musto et al. CANCER
- Signaling cross-talk between TGF-β/BMP and other pathways
- (2008) Xing Guo et al. CELL RESEARCH
- Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma
- (2008) Martin Kaiser et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- 153Sm: its use in multiple myeloma and report of a clinical experience
- (2008) Elisabetta Abruzzese et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Osteocyte-Derived Sclerostin Inhibits Bone Formation: Its Role in Bone Morphogenetic Protein and Wnt Signaling
- (2008) Peter ten Dijke et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
- (2008) Deborah J Heath et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of pathologic fractures on survival in multiple myeloma patients: a case control study
- (2008) Mehmet Sonmez et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer
- (2008) P. D. Ottewell et al. JNCI-Journal of the National Cancer Institute
- Treatment of newly diagnosed myeloma
- (2008) A Palumbo et al. LEUKEMIA
- N-Cadherin Interacts with Axin and LRP5 To Negatively Regulate Wnt/ -Catenin Signaling, Osteoblast Function, and Bone Formation
- (2008) E. Hay et al. MOLECULAR AND CELLULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search